NEW YORK (GenomeWeb News) – Precision Biosciences said today that the US Patent and Trademark Office has granted the firm's request to reexamine a pair of US patents that Cellectis has asserted against Precision in ongoing patent-infringement litigation.

The patents, US Nos. 6,610,545 and 7,309,605, deal with DNA vectors that can be used in gene mapping and site-directed gene insertion. Cellectis has a license to the patents, which are owned by the Institut Pasteur and Universite Pierre et Marie Curie.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.